| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 54.460 | 185.883 | 197.031 | - | - | - |
| Total Income - EUR | - | - | - | - | 54.460 | 185.890 | 197.042 | - | - | - |
| Total Expenses - EUR | - | - | - | - | 14.508 | 40.270 | 43.223 | - | - | - |
| Gross Profit/Loss - EUR | - | - | - | - | 39.952 | 145.620 | 153.819 | - | - | - |
| Net Profit/Loss - EUR | - | - | - | - | 39.407 | 143.902 | 151.849 | - | - | - |
| Employees | - | - | - | - | 5 | 5 | 5 | - | - | - |
Check the financial reports for the company - Neuro Sam Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 2.476 | 2.279 | 2.284 | - | - | - |
| Current Assets | - | - | - | - | 38.775 | 143.803 | 152.821 | - | - | - |
| Inventories | - | - | - | - | 0 | 0 | 0 | - | - | - |
| Receivables | - | - | - | - | 36.644 | 126.566 | 127.979 | - | - | - |
| Cash | - | - | - | - | 2.131 | 17.237 | 24.843 | - | - | - |
| Shareholders Funds | - | - | - | - | 39.105 | 143.952 | 151.898 | - | - | - |
| Social Capital | - | - | - | - | 42 | 41 | 40 | - | - | - |
| Debts | - | - | - | - | 2.146 | 2.131 | 3.208 | - | - | - |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Neuro Sam Srl